KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Receivables - Other: 2018-2025

Historic Receivables - Other for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $3.9 million.

  • Twist Bioscience's Receivables - Other rose 89.91% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 89.91%. This contributed to the annual value of $3.9 million for FY2025, which is 89.91% up from last year.
  • Latest data reveals that Twist Bioscience reported Receivables - Other of $3.9 million as of FY2025, which was up 89.91% from $2.0 million recorded in FY2024.
  • Over the past 5 years, Twist Bioscience's Receivables - Other peaked at $3.9 million during FY2025, and registered a low of $2.0 million during FY2024.
  • In the last 3 years, Twist Bioscience's Receivables - Other had a median value of $2.8 million in 2023 and averaged $2.9 million.
  • Per our database at Business Quant, Twist Bioscience's Receivables - Other spiked by 145.74% in 2021 and then declined by 27.88% in 2024.
  • Over the past 5 years, Twist Bioscience's Receivables - Other (Yearly) stood at $2.3 million in 2021, then spiked by 45.49% to $3.4 million in 2022, then fell by 17.18% to $2.8 million in 2023, then declined by 27.88% to $2.0 million in 2024, then spiked by 89.91% to $3.9 million in 2025.